Hearing Impaired: Clinical Trials

8 trials for Hearing Impaired, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting. 3 Phase 2, 2 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Not applicable2Completed 2
Phase 12Recruiting 1, Unknown 1

Follow Hearing Impaired: new trials by email Literature Review of Hearing Impaired trials Research Report on Hearing Impaired

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
RBANS-H in Older Patients Before and After Cochlear Implantation: A Protocol for a Prospective Study
Cochlear implant - Hearing Impaired
UnknownUniversity Hospital, Antwerp202015-07-012016-06-10
Educational Program for Hearing Aid Users With Internet Support
Intervention group, Control group - Hearing Impaired
Not applicableCompletedSodra Alvsborgs Hospital742013-04-012016-04-25
Brain and Cognitive Changes After Reasoning or Physical Training in Cognitively Normal Seniors
SMART- Strategic Memory and Reasoning Training, Physical Exercise - Hearing Impaired
Not applicableCompletedThe University of Texas at Dallas602012-06-012016-07-11
Cochlear Implant PDA Based Research Platform
ciPDA - Hearing Impaired
Phase 1UnknownPhilip Loizou602011-06-012012-06-15
Functioning, Disability, and Quality of Life in the Adult Hearing Impaired
Hearing Aids - Hearing Impaired
Phase 2CompletedUS Department of Veterans Affairs3302001-07-012009-02-11
Measurement and Prediction of Outcomes of Amplification
Hearing - Hearing Impaired
Phase 2CompletedUS Department of Veterans Affairs1201999-10-012009-01-21
Effects of Stimulus Validity on Speech Recognition
Talker variability - Hearing Impaired
CompletedUS Department of Veterans Affairs801998-04-012009-01-21

Narrower conditions

Hearing Loss (8)  ·  Auditory Diseases, Central (1)  ·  Hearing Disorders (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Motor Activity (1)  ·  Patient Participation (1)  ·  Presbycusis (1)

Broader conditions

Ear Diseases (8)  ·  Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Otorhinolaryngologic Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Sensation Disorders (8)  ·  Signs and Symptoms (8)  ·  Hearing Disorders (7)  ·  Behavior (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Health Behavior (1)  ·  Language Disorders (1)  ·  Neurobehavioral Manifestations (1)

Interventions

Clemastine (1)  ·  Cochlear Implants (1)  ·  Control Groups (1)  ·  Exercise (1)  ·  Hearing (1)  ·  Hearing Aids (1)  ·  Placebo Effect (1)

Sponsors

US Department of Veterans Affairs (3)  ·  Philip Loizou (1)  ·  Sodra Alvsborgs Hospital (1)  ·  The University of Texas at Dallas (1)  ·  University Hospital, Antwerp (1)  ·  University of Colorado, Denver (1)

Countries

United States (6)  ·  Belgium (1)  ·  Sweden (1)

Top investigators

Achim Klug, PhD (1)  ·  Gerhard Andersson, Professor (1)  ·  Harvey Abrams, PhD (1)  ·  John Fryer, Ph.D., Asst. Director (1)  ·  John Fryer, Ph.D., Program Analyst (1)  ·  Nancy Roceleau, Program Analyst (1)  ·  Nancy Rocheleau, Program Analyst (1)  ·  Philip Loizou, PhD (1)  ·  Samuel A Budoff, PhD, MS (1)  ·  Sandra Chapman, Ph.D. (1)  ·  Thomas Lunner, Professor (1)

Results publications

PMID 16244757, PMID 16244758, PMID 16244759, PMID 27895549, PMID 28592571, PMID 29121545, PMID 35970164